What is the projected market valuation for the US plant hormones market in 2035?

The projected market valuation for the US plant hormones market in 2035 is $1050.0 Million. Read More

What was the market valuation of the US plant hormones market in 2024?

The market valuation of the US plant hormones market was $500.0 Million in 2024. Read More

What is the expected CAGR for the US plant hormones market during the forecast period 2025 - 2035?

The expected CAGR for the US plant hormones market during the forecast period 2025 - 2035 is 6.98%. Read More

Which segment had the highest valuation in the type category in 2024?

In 2024, the segment with the highest valuation in the type category was Ethylene, valued at $120.0 Million. Read More

What are the key players in the US plant hormones market?

Key players in the US plant hormones market include BASF SE, Syngenta AG, Bayer AG, FMC Corporation, Nufarm Limited, Valagro S.p.A., UPL Limited, and Koppert Biological Systems. Read More

Which formulation segment is expected to show significant growth by 2035?

The Solutions segment, valued at $200.0 Million in 2024, is expected to show significant growth, reaching $420.0 Million by 2035. Read More

What is the valuation of the Growth Promoters segment in 2024?

The Growth Promoters segment was valued at $300.0 Million in 2024. Read More

How does the valuation of Gibberellins compare to Cytokinins in 2024?

In 2024, Gibberellins were valued at $70.0 Million, whereas Cytokinins were valued at $80.0 Million, indicating a slight difference. Read More

What is the projected valuation for the Fruits & Vegetables application segment by 2035?

The projected valuation for the Fruits & Vegetables application segment is expected to reach $420.0 Million by 2035. Read More

Which function segment is anticipated to grow more rapidly, Growth Promoters or Growth Inhibitors?

The Growth Promoters segment, valued at $300.0 Million in 2024, is anticipated to grow more rapidly compared to the Growth Inhibitors segment, which was valued at $200.0 Million. Read More

US Plant Hormones Market

ID: MRFR/Agri/13227-HCR

128 Pages

Snehal Singh

Last Updated: April 06, 2026

US Plant Hormones Market Size, Share, Industry Trend & Analysis Research Report By Type (Auxins, Cytokinins, Ethylene, Gibberellins, Others), By Formulation (Solutions, Granules, Wet Powders, Others), By Function (Growth Promoters, Growth Inhibitors) and By Application (Fruits & Vegetables, Cereals & Pulses, Oilseeds & Grains, Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Forecast Till 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Construction, BY Type (USD Million)
  1. 4.1.1 Auxins
  2. 4.1.2 Cytokinins
  3. 4.1.3 Ethylene
  4. 4.1.4 Gibberellins
  5. 4.1.5 Others
2. 4.2 Construction, BY Formulation (USD Million)
  1. 4.2.1 Solutions
  2. 4.2.2 Granules
  3. 4.2.3 Wet Powders
  4. 4.2.4 Others
3. 4.3 Construction, BY Function (USD Million)
  1. 4.3.1 Growth Promoters
  2. 4.3.2 Growth Inhibitors
4. 4.4 Construction, BY Application (USD Million)
  1. 4.4.1 Fruits & Vegetables
  2. 4.4.2 Cereals & Pulses
  3. 4.4.3 Oilseeds & Grains
  4. 4.4.4 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Construction
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 BASF SE (DE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Syngenta AG (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Bayer AG (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 FMC Corporation (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Nufarm Limited (AU)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Valagro S.p.A. (IT)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 UPL Limited (IN)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Koppert Biological Systems (NL)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY FORMULATION
4. 6.4 US MARKET ANALYSIS BY FUNCTION
5. 6.5 US MARKET ANALYSIS BY APPLICATION
6. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CONSTRUCTION
9. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
11. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION
12. 6.12 CONSTRUCTION, BY TYPE, 2024 (% SHARE)
13. 6.13 CONSTRUCTION, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 CONSTRUCTION, BY FORMULATION, 2024 (% SHARE)
15. 6.15 CONSTRUCTION, BY FORMULATION, 2024 TO 2035 (USD Million)
16. 6.16 CONSTRUCTION, BY FUNCTION, 2024 (% SHARE)
17. 6.17 CONSTRUCTION, BY FUNCTION, 2024 TO 2035 (USD Million)
18. 6.18 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE)
19. 6.19 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY FORMULATION, 2025-2035 (USD Million)
  3. 7.2.3 BY FUNCTION, 2025-2035 (USD Million)
  4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Construction Market Segmentation

Construction By Type (USD Million, 2025-2035)

Auxins
Cytokinins
Ethylene
Gibberellins
Others

Construction By Formulation (USD Million, 2025-2035)

Solutions
Granules
Wet Powders
Others

Construction By Function (USD Million, 2025-2035)

Growth Promoters
Growth Inhibitors

Construction By Application (USD Million, 2025-2035)

Fruits & Vegetables
Cereals & Pulses
Oilseeds & Grains
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”